Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases

Toxicon

Volumn 56, Issue 3, 2010, Pages 282-294

  Maresca, Marc ^a   Fantini, Jacques ^a  

^a University of Mediterranée   (France)

Author keywords

Bacterial translocation; Chronic intestinal inflammatory disease; Inflammatory bowel disease; Intestine; Mycotoxin

Indexed keywords

AFLATOXIN; FUMONISIN B1; MYCOTOXIN; OCHRATOXIN; PATULIN; T 2 TOXIN; VOMITOXIN; ZEARALENONE;

ADAPTIVE IMMUNITY; BACTERIAL TRANSLOCATION; CELIAC DISEASE; CROHN DISEASE; DISEASE PREDISPOSITION; ENTERITIS; EXPERIMENTAL MODEL; FOOD CONTAMINATION; GENETIC PREDISPOSITION; GENOTOXICITY; HUMAN; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MUCOSAL IMMUNITY; MUCUS SECRETION; MUTAGENIC ACTIVITY; MYCOTOXICOSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ULCERATIVE COLITIS;

CHRONIC DISEASE; DISEASE SUSCEPTIBILITY; HUMANS; INFLAMMATORY BOWEL DISEASES; MYCOTOXINS; RISK FACTORS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 77954144537     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.04.016     Document Type: Review

References (163)

1. Abid-Essefi S., Baudrimont I., Hassen W., Ouanes Z., Mobio T.A., Anane R., Creppy E.E., Bacha H. DNA fragmentation, apoptosis and cell cycle arrest induced by zearalenone in cultured DOK, Vero and Caco-2 cells: prevention by vitamin E. Toxicology 2003, 192:237-248.
2. Abid-Essefi S., Ouanes Z., Hassen W., Baudrimont I., Creppy E.E., Bacha H. Cytotoxicity, inhibition of DNA and protein syntheses and oxidative damage in cultured cells exposed to zearalenone. Toxicol. in Vitro 2004, 18:467-474.
3. Alaedini A., Green P.H. Autoantibodies in celiac disease. Autoimmunity 2008, 41:19-26.
4. Al-Anati L., Petzinger E. Immunotoxic activity of ochratoxin A. J. Vet. Pharmacol. Ther. 2006, 29:79-90.
5. Ashorn S., Välineva T., Kaukinen K., Ashorn M., Braun J., Raukola H., Rantala I., Collin P., Mäki M., Luukkaala T., Iltanen S. Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J. Clin. Immunol. 2009, 29:190-195.
6. Baumgart D.C., Carding S.R. Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640.
7. Becker B., Bresch H., Schillinger U., Thiel P.G. The effect of fumonisin B1 on the growth of bacteria. World J. Microbiol. Biotechnol. 1997, 13:539-543.
8. Bennett J.W., Klich M. Mycotoxins. Clin. Microbiol. Rev. 2003, 16:497-516.
9. Bernstein C.N., Wajda A., Svenson L.W., MacKenzie A., Koehoorn M., Jackson M., Fedorak R., Israel D., Blanchard J.F. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am. J. Gastroenterol. 2006, 101:1559-1568.
10. Betina V. Structure-activity relationships among mycotoxins. Chem. Biol. Interact 1989, 71:105-146.
11. Bhandari N., Brown C.C., Sharma R.P. Fumonisin B1-induced localized activation of cytokine network in mouse liver. Food Chem. Toxicol. 2002, 40:1483-1491.
12. Bondy G.S., Pestka J.J. Immunomodulation by fungal toxins. J. Toxicol. Environ. Health B Crit. Rev. 2000, 3:109-143.
13. Bony S., Carcelen M., Olivier L., Devaux A. Genotoxicity assessment of deoxynivalenol in the Caco-2 cell line model using the Comet assay. Toxicol. Lett. 2006, 166:67-76.
14. Bouaziz C., Abid-Essefi S., Bouslimi A., El Golli E., Bacha H. Cytotoxicity and related effects of T-2 toxin on cultured Vero cells. Toxicon 2006, 48:343-352.
15. Bouhet S., Hourcade E., Loiseau N., Fikry A., Martinez S., Roselli M., Galtier P., Mengheri E., Oswald I.P. The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells. Toxicol. Sci. 2004, 77:165-171.
16. Bouhet S., Le Dorze E., Peres S., Fairbrother J.M., Oswald I.P. Mycotoxin fumonisin B1 selectively down-regulates the basal IL-8 expression in pig intestine: in vivo and in vitro studies. Food Chem. Toxicol. 2006, 44:1768-1773.
17. Bouhet S., Oswald I.P. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet. Immunol. Immunopathol 2005, 108:199-209.
18. Bouhet S., Oswald I.P. The intestine as a possible target for fumonisin toxicity. Mol. Nutr. Food Res. 2007, 51:925-931.
19. Bouslimi A., Bouaziz C., Ayed-Boussema I., Hassen W., Bacha H. Individual and combined effects of ochratoxin A and citrinin on viability and DNA fragmentation in cultured Vero cells and on chromosome aberrations in mice bone marrow cells. Toxicology 2008, 251:1-7.
20. Briani C., Samaroo D., Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun. Rev. 2008, 7:644-650.
21. Brown T.P., Rottinghaus G.E., Williams M.E. Fumonisin mycotoxicosis in broilers: performance and pathology. Avian Dis. 1992, 36:450-454.
22. Brunet J.L., Maresca M., Fantini J., Belzunces L.P. Human intestinal absorption of imidacloprid with Caco-2 cells as enterocyte model. Toxicol. Appl. Pharmacol. 2004, 194:1-9.
23. Brunet J.L., Maresca M., Fantini J., Belzunces L.P. Intestinal absorption of the acetamiprid neonicotinoid by Caco-2 cells: transepithelial transport, cellular uptake and efflux. J. Environ. Sci. Health B 2008, 43:261-270.
24. Bryden W.L. Mycotoxins in the food chain: human health implications. Asia Pac. J. Clin. Nutr. 2007, 16:95-101.
25. Buisine M.P., Desreumaux P., Debailleul V., Gambiez L., Geboes K., Ectors N., Delescaut M.P., Degand P., Aubert J.P., Colombel J.F., Porchet N. Abnormalities in mucin gene expression in Crohn's disease. Inflamm. Bowel Dis. 1999, 5:24-32.
26. Buret A.G. How stress induces intestinal hypersensitivity. Am. J. Pathol. 2006, 168:3-5.
27. Caloni F., Stammati A., Friggè G., De Angelis I. Aflatoxin M1 absorption and cytotoxicity on human intestinal in vitro model. Toxicon 2006, 47:409-415.
28. Calvert T.W., Aidoo K.E., Candlish A.G., Fuat A.R. Comparison of in vitro cytotoxicity of Fusarium mycotoxins, deoxynivalenol, T-2 toxin and zearalenone on selected human epithelial cell lines. Mycopathologia 2005, 159:413-419.
29. Campbell A.W., Thrasher J.D., Gray M.R., Vojdani A. Mold and mycotoxins: effects on the neurological and immune systems in humans. Adv. Appl. Microbiol. 2004, 55:375-406.
30. Cario E. Bacterial interactions with cells of the intestinal mucosa: toll-like receptors and NOD2. Gut 2005, 54:1182-1193.
31. Carroccio A., Cavataio F., Montalto G., Paparo F., Troncone R., Iacono G. Treatment of giardiasis reverses " active" coeliac disease to " latent" coeliac disease. Eur. J. Gastroenterol. Hepatol. 2001, 13:1101-1105.
32. Cavret S., Lecoeur S. Fusariotoxin transfer in animal. Food Chem. Toxicol. 2006, 44:444-453.
33. Chapman J.A., Terr A.I., Jacobs R.L., Charlesworth E.N., Bardana E.J. Toxic mold: phantom risk vs science. Ann. Allergy Asthma Immunol. 2003, 91:222-232.
34. Chen F., Ma Y., Xue C., Ma J., Xie Q., Wang G., Bi Y., Cao Y. The combination of deoxynivalenol and zearalenone at permitted feed concentrations causes serious physiological effects in young pigs. J. Vet. Sci. 2008, 9:39-44.
35. Choi H.J., Yang H., Park S.H., Moon Y. HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol. Toxicol. Appl. Pharmacol. 2009, 240:46-54.
36. Clark E., Hoare C., Tanianis-Hughes J., Carlson G.L., Warhurst G. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 2005, 128:1258-1267.
37. Clark H.A., Snedeker S.M. Ochratoxin A: its cancer risk and potential for exposure. J. Toxicol. Environ. Health B Crit. Rev. 2006, 9:265-296.
38. Creppy E.E. Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicol. Lett. 2002, 127:19-28.
39. Creppy E.E., Chiarappa P., Baudrimont I., Borracci P., Moukha S., Carratù M.R. Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity?. Toxicology 2004, 201:115-123.
40. Danese S., Sans M., Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 2004, 3:394-400.
41. De Hertogh G., Aerssens J., Geboes K.P., Geboes K. Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J. Gastroenterol. 2008, 14:845-852.
42. Ehrich M., Driscoll C., Gross W.B. Effect of dietary exposure to aflatoxin B1 on resistance of young chickens to organophosphate pesticide challenge. Avian Dis. 1985, 29:715-720.
43. Fabia R., Ar'Rajab A., Johansson M.L., Andersson R., Willén R., Jeppsson B., Molin G., Bengmark S. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion 1993, 54:248-255.
44. Frisvad J.C., Thrane U., Samson R.A., Pitt J.I. Important mycotoxins and the fungi which produce them. Adv. Exp. Med. Biol. 2006, 571:3-31.
45. Fuchs R., Peraica M. Ochratoxin A in human kidney diseases. Food Addit Contam. 2005, 22:53-57.
46. Fukata T., Sasai K., Baba E., Arakawa A. Effect of ochratoxin A on Salmonella typhimurium-challenged layer chickens. Avian Dis. 1996, 40:924-926.
47. Fung F., Clark R.F. Health effects of mycotoxins: a toxicological overview. J. Toxicol. Clin. Toxicol. 2004, 42:217-234.
48. Goldman R., Shields P.G. Food mutagens. J. Nutr. 2003, 133:965S-973S.
49. Gratz S., Wu Q.K., El-Nezami H., Juvonen R.O., Mykkänen H., Turner P.C. Lactobacillus rhamnosus strain GG reduces aflatoxin B1 transport, metabolism, and toxicity in Caco-2 cells. Appl. Environ. Microbiol. 2007, 73:3958-3964.
50. Guerra M.C., Galvano F., Bonsi L., Speroni E., Costa S., Renzulli C., Cervellati R. Cyanidin-3-O-beta-glucopyranoside, a natural free-radical scavenger against aflatoxin B1- and ochratoxin A-induced cell damage in a human hepatoma cell line (Hep G2) and a human colonic adenocarcinoma cell line (Caco-2). Br. J. Nutr. 2005, 94:211-220.
51. Habib N.A., Dawson P.M., Krausz T., Blount M.A., Kersten D., Wood C.B. A study of histochemical changes in mucus from patients with ulcerative colitis, Crohn's disease, and diverticular disease of the colon. Dis. Colon Rectum 1986, 29:15-17.
52. Hardin B.D., Kelman B.J., Saxon A. Adverse human health effects associated with molds in the indoor environment. J. Occup. Environ. Med. 2003, 45:470-478.
53. Heap G.A., van Heel D.A. Genetics and pathogenesis of coeliac disease. Semin. Immunol. 2009, 21:346-354.
54. Heap G.A., van Heel D.A. The genetics of chronic inflammatory diseases. Hum. Mol. Genet. 2009, 18:R101-R106.
55. Hendry K.M., Cole E.C. A review of mycotoxins in indoor air. J. Toxicol. Environ. Health 1993, 38:183-198.
56. Heussner A.H., Dietrich D.R., O'Brien E. In vitro investigation of individual and combined cytotoxic effects of ochratoxin A and other selected mycotoxins on renal cells. Toxicol. in Vitro 2006, 20:332-341.
57. Hollander D. Inflammatory bowel diseases and brain-gut axis. J. Physiol. Pharmacol. 2003, 54:183-190.
58. Hussain S., Khan M.Z., Khan A., Javed I., Asi M.R. Toxico-pathological effects in rats induced by concurrent exposure to aflatoxin and cypermethrin. Toxicon 2009, 53:33-41.
59. Jabri B., Kasarda D.D., Green P.H. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol. Rev. 2005, 206:219-231.
60. Jeffrey A.M., Williams G.M. Risk assessment of DNA-reactive carcinogens in food. Toxicol. Appl. Pharmacol. 2005, 207:628-635.
61. Jia Q., Pestka J.J. Role of cyclooxygenase-2 in deoxynivalenol-induced immunoglobulin a nephropathy. Food Chem. Toxicol. 2005, 43:721-728.
62. Jung K.Y., Endou H. Nephrotoxicity assessment by measuring cellular ATP content. II. Intranephron site of ochratoxin A nephrotoxicity. Toxicol. Appl. Pharmacol. 1989, 100:383-390.
63. Kabak B., Dobson A.D., Var I. Strategies to prevent mycotoxin contamination of food and animal feed: a review. Crit. Rev. Food Sci. Nutr. 2006, 46:593-619.
64. Kaczmarski M., Kurzatkowska B. The contribution of some environmental factors to the development of cow's milk and gluten intolerance in children. Rocz Akad Med. Bialymst 1988, 33-34:151-165.
65. Kagnoff M.F., Paterson Y.J., Kumar P.J., Kasarda D.D., Carbone F.R., Unsworth D.J., Austin R.K. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 1987, 28:995-1001.
66. Kalischuk L.D., Inglis G.D., Buret A.G. Campylobacter jejuni induces transcellular translocation of commensal bacteria via lipid rafts. Gut Pathog. 2009, 1:2.
67. Kasuga F., Hara-Kudo Y., Saito N., Kumagai S., Sugita-Konishi Y. In vitro effect of deoxynivalenol on the differentiation of human colonic cell lines Caco-2 and T84. Mycopathologia 1998, 142:161-167.
68. Klein R.M., McKenzie J.C. The role of cell renewal in the ontogeny of the intestine. I. Cell proliferation patterns in adult, fetal, and neonatal intestine. J. Pediatr. Gastroenterol. Nutr. 1983, 2:10-43.
69. Knasmüller S., Mersch-Sundermann V., Kevekordes S., Darroudi F., Huber W.W., Hoelzl C., Bichler J., Majer B.J. Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 2004, 198:315-328.
70. Knight P., Campbell B.J., Rhodes J.M. Host-bacteria interaction in inflammatory bowel disease. Br. Med. Bull. 2008, 88:95-113.
71. Koshinsky H.A., Khachatourians G.G. Trichothecene synergism, additivity, and antagonism: the significance of the maximally quiescent ratio. Nat. Toxins 1992, 1:38-47.
72. Kouadio J.H., Dano S.D., Moukha S., Mobio T.A., Creppy E.E. Effects of combinations of Fusarium mycotoxins on the inhibition of macromolecular synthesis, malondialdehyde levels, DNA methylation and fragmentation, and viability in Caco-2 cells. Toxicon 2007, 49:306-317.
73. Kouadio J.H., Mobio T.A., Baudrimont I., Moukha S., Dano S.D., Creppy E.E. Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology 2005, 213:56-65.
74. Lakatos P.L., Fischer S., Lakatos L., Gal I., Papp J. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take " toll" ?. World J. Gastroenterol. 2006, 12:1829-1841.
75. Lambert D., O'Neill C.A., Padfield P.J. Methyl-beta-cyclodextrin increases permeability of Caco-2 cell monolayers by displacing specific claudins from cholesterol rich domains associated with tight junctions. Cell Physiol. Biochem. 2007, 20:495-506.
76. Lambert D., Padfield P.J., McLaughlin J., Cannell S., O'Neill C.A. Ochratoxin A displaces claudins from detergent resistant membrane microdomains. Biochem. Biophys. Res. Commun. 2007, 358:632-636.
77. Lambert G.P. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J. Anim. Sci. 2009, 87:E101-E108.
78. Li M., Cuff C.F., Pestka J.J. Modulation of murine host response to enteric reovirus infection by the trichothecene deoxynivalenol. Toxicol. Sci. 2005, 87:134-145.
79. Li M., Cuff C.F., Pestka J.J. T-2 toxin impairment of enteric reovirus clearance in the mouse associated with suppressed immunoglobulin and IFN-gamma responses. Toxicol. Appl. Pharmacol. 2006, 214:318-325.
80. Loiseau N., Debrauwer L., Sambou T., Bouhet S., Miller J.D., Martin P.G., Viadère J.L., Pinton P., Puel O., Pineau T., Tulliez J., Galtier P., Oswald I.P. Fumonisin B1 exposure and its selective effect on porcine jejunal segment: sphingolipids, glycolipids and trans-epithelial passage disturbance. Biochem. Pharmacol. 2007, 74:144-152.
81. Luft P., Oostingh G.J., Gruijthuijsen Y., Horejs-Hoeck J., Lehmann I., Duschl A. Patulin influences the expression of Th1/Th2 cytokines by activated peripheral blood mononuclear cells and T cells through depletion of intracellular glutathione. Environ. Toxicol. 2008, 23:84-95.
82. Luongo D., De Luna R., Russo R., Severino L. Effects of four Fusarium toxins (fumonisin B(1), alpha-zearalenol, nivalenol and deoxynivalenol) on porcine whole-blood cellular proliferation. Toxicon 2008, 52:156-162.
83. Luongo D., Severino L., Bergamo P., De Luna R., Lucisano A., Rossi M. Interactive effects of fumonisin B1 and alpha-zearalenol on proliferation and cytokine expression in Jurkat T cells. Toxicol. in Vitro 2006, 20:1403-1410.
84. Macfarlane S., Steed H., Macfarlane G.T. Intestinal bacteria and inflammatory bowel disease. Crit. Rev. Clin. Lab. Sci. 2009, 46:25-54.
85. Macutkiewicz C., Carlson G., Clark E., Dobrindt U., Roberts I., Warhurst G. Characterisation of Escherichia coli strains involved in transcytosis across gut epithelial cells exposed to metabolic and inflammatory stress. Microbes Infect. 2008, 10:424-431.
86. Mahfoud R., Maresca M., Garmy N., Fantini J. The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. Toxicol. Appl. Pharmacol. 2002, 181:209-218.
87. Mahfoud R., Maresca M., Santelli M., Pfohl-Leszkowicz A., Puigserver A., Fantini J. pH-dependent interaction of fumonisin B1 with cholesterol: physicochemical and molecular modeling studies at the air-water interface. J. Agric. Food Chem. 2002, 50:327-331.
88. Maresca M., Mahfoud R., Garmy N., Fantini J. The mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells. J. Nutr. 2002, 132:2723-2731.
89. Maresca M., Mahfoud R., Pfohl-Leszkowicz A., Fantini J. The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Toxicol. Appl. Pharmacol. 2001, 176:54-63.
90. Maresca M., Yahi N., Younès-Sakr L., Boyron M., Caporiccio B., Fantini J. Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria. Toxicol. Appl. Pharmacol. 2008, 228:84-92.
91. Marin D.E., Taranu I., Bunaciu R.P., Pascale F., Tudor D.S., Avram N., Sarca M., Cureu I., Criste R.D., Suta V., Oswald I.P. Changes in performance, blood parameters, humoral and cellular immune responses in weanling piglets exposed to low doses of aflatoxin. J. Anim. Sci. 2002, 80:1250-1257.
92. Mattsson J.L. Mixtures in the real world: the importance of plant self-defense toxicants, mycotoxins, and the human diet. Toxicol. Appl. Pharmacol. 2007, 223:125-132.
93. Mazur L.J., Kim J. Spectrum of noninfectious health effects from molds. Pediatrics 2006, 118:e1909-e1926.
94. McKay D.M. Good bug, bad bug: in the case of enteric inflammatory disease does the epithelium decide?. Mem. Inst. Oswaldo Cruz 2005, 100:205-210.
95. McKean C., Tang L., Billam M., Tang M., Theodorakis C.W., Kendall R.J., Wang J.S. Comparative acute and combinative toxicity of aflatoxin B1 and T-2 toxin in animals and immortalized human cell lines. J. Appl. Toxicol. 2006, 26:139-147.
96. McKean C., Tang L., Tang M., Billam M., Wang Z., Theodorakis C.W., Kendall R.J., Wang J.S. Comparative acute and combinative toxicity of aflatoxin B1 and fumonisin B1 in animals and human cells. Food Chem. Toxicol. 2006, 44:868-876.
97. McLaughlin J., Lambert D., Padfield P.J., Burt J.P., O'Neill C.A. The mycotoxin patulin, modulates tight junctions in caco-2 cells. Toxicol. in Vitro 2009, 23:83-89.
98. McLaughlin J., Padfield P.J., Burt J.P., O'Neill C.A. Ochratoxin A increases permeability through tight junctions by removal of specific claudin isoforms. Am. J. Physiol. Cell Physiol. 2004, 287:C1412-C1417.
99. Montagne L., Piel C., Lallès J.P. Effect of diet on mucin kinetics and composition: nutrition and health implications. Nutr. Rev. 2004, 62:105-114.
100. Moon Y., Yang H., Lee S.H. Modulation of early growth response gene 1 and interleukin-8 expression by ribotoxin deoxynivalenol (vomitoxin) via ERK1/2 in human epithelial intestine 407 cells. Biochem. Biophys. Res. Commun. 2007, 362:256-262.
101. Moon Y., Yang H., Park S.H. Hypo-responsiveness of interleukin-8 production in human embryonic epithelial intestine 407 cells independent of NF-kappaB pathway: new lessons from endotoxin and ribotoxic deoxynivalenol. Toxicol. Appl. Pharmacol. 2008, 231:94-102.
102. Mulder S.J., Mulder-Bos G.C. Most probable origin of coeliac disease is low immune globulin A in the intestine caused by malfunction of Peyer's patches. Med. Hypotheses 2006, 66:757-762.
103. Nazli A., Wang A., Steen O., Prescott D., Lu J., Perdue M.H., Söderholm J.D., Sherman P.M., McKay D.M. Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia. Infect. Immun. 2006, 74:192-201.
104. Nazli A., Yang P.C., Jury J., Howe K., Watson J.L., Söderholm J.D., Sherman P.M., Perdue M.H., McKay D.M. Epithelia under metabolic stress perceive commensal bacteria as a threat. Am. J. Pathol. 2004, 164:947-957.
105. Nusrat A., Parkos C.A., Verkade P., Foley C.S., Liang T.W., Innis-Whitehouse W., Eastburn K.K., Madara J.L. Tight junctions are membrane microdomains. J. Cell Sci. 2000, 113:1771-1781.
106. Obremski K., Gajecka M., Zielonka L., Jakimiuk E., Gajecki M. Morphology and ultrastructure of small intestine mucosa in gilts with zearalenone mycotoxicosis. Pol J. Vet. Sci. 2005, 8:301-307.
107. Obremski K., Zielonka L., Gajecka M., Jakimiuk E., Bakuła T., Baranowski M., Gajecki M. Histological estimation of the small intestine wall after administration of feed containing deoxynivalenol, T-2 toxin and zearalenone in the pig. Pol J. Vet. Sci. 2008, 11:339-345.
108. Oswald I.P., Desautels C., Laffitte J., Fournout S., Peres S.Y., Odin M., Le Bars P., Le Bars J., Fairbrother J.M. Mycotoxin fumonisin B1 increases intestinal colonization by pathogenic Escherichia coli in pigs. Appl. Environ. Microbiol. 2003, 69:5870-5874.
109. Osweiler G.D. Mycotoxins. Contemporary issues of food animal health and productivity. Vet. Clin. North Am. Food Anim. Pract. 2000, 16:511-530.
110. Parnell N., Ciclitira P.J. Celiac disease. Curr. Opin. Gastroenterol. 1999, 15:120-124.
111. Peraica M., Radić B., Lucić A., Pavlović M. Toxic effects of mycotoxins in humans. Bull. World Health Organ 1999, 77:754-766.
112. Pestka J.J. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions. Toxicol. Lett. 2003, 140-141:287-295.
113. Pestka J.J., Smolinski A.T. Deoxynivalenol: toxicology and potential effects on humans. J. Toxicol. Environ. Health B Crit. Rev. 2005, 8:39-69.
114. Pestka J.J., Yike I., Dearborn D.G., Ward M.D., Harkema J.R. Stachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: new insights into a public health enigma. Toxicol. Sci. 2008, 104:4-26.
115. Pfohl-Leszkowicz A., Manderville R.A. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51:61-99.
116. Pineiro M. Mycotoxins: natural toxins of agricultural and health significance. Forum Nutr. 2003, 56:409-412.
117. Pineton de Chambrun G., Colombel J.F., Poulain D., Darfeuille-Michaud A. Pathogenic agents in inflammatory bowel diseases. Curr. Opin. Gastroenterol. 2008, 24:440-447.
118. Pinton P., Nougayrède J.P., Del Rio J.C., Moreno C., Marin D.E., Ferrier L., Bracarense A.P., Kolf-Clauw M., Oswald I.P. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces Claudin expression. Toxicol. Appl. Pharmacol. 2009, 237:41-48.
119. Pitt J.I. Toxigenic fungi and mycotoxins. Br. Med. Bull. 2000, 56:184-192.
120. Pitt J.I. Toxigenic fungi: which are important?. Med. Mycol. 2000, 38:17-22.
121. Pitt J.I., Basílico J.C., Abarca M.L., López C. Mycotoxins and toxigenic fungi. Med. Mycol. 2000, 38:41-46.
122. Plot L., Amital H. Infectious associations of Celiac disease. Autoimmun. Rev. 2009, 8:316-319.
123. Preston R.J., Williams G.M. DNA-reactive carcinogens: mode of action and human cancer hazard. Crit. Rev. Toxicol. 2005, 35:673-683.
124. Pullan R.D., Thomas G.A., Rhodes M., Newcombe R.G., Williams G.T., Allen A., Rhodes J. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 1994, 35:353-359.
125. Ranaldi G., Mancini E., Ferruzza S., Sambuy Y., Perozzi G. Effects of red wine on ochratoxin A toxicity in intestinal Caco-2/TC7 cells. Toxicol. in Vitro 2007, 21:204-210.
126. Rasooly L., Pestka J.J. Vomitoxin-induced dysregulation of serum IgA, IgM and IgG reactive with gut bacterial and self antigens. Food Chem. Toxicol. 1992, 30:499-504.
127. Richard J.L. Some major mycotoxins and their mycotoxicoses - an overview. Int. J. Food Microbiol. 2007, 119:3-10.
128. Robbins C.A., Swenson L.J., Nealley M.L., Gots R.E., Kelman B.J. Health effects of mycotoxins in indoor air: a critical review. Appl. Occup. Environ. Hyg. 2000, 15:773-784.
129. Rocha O., Ansari K., Doohan F.M. Effects of trichothecene mycotoxins on eukaryotic cells: a review. Food Addit Contam. 2005, 22:369-378.
130. Rogers C.A. Indoor fungal exposure. Immunol. Allergy Clin. North Am. 2003, 23:501-518.
131. Sánchez E., Nadal I., Donat E., Ribes-Koninckx C., Calabuig M., Sanz Y. Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children. BMC Gastroenterol. 2008, 8:50.
132. Scaldaferri F., Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J. Dig. Dis. 2007, 8:171-178.
133. Schultsz C., Moussa M., van Ketel R., Tytgat G.N., Dankert J. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J. Clin. Pathol. 1997, 50:573-579.
134. Seksik P., Rigottier-Gois L., Gramet G., Sutren M., Pochart P., Marteau P., Jian R., Doré J. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003, 52:237-242.
135. Sergent T., Parys M., Garsou S., Pussemier L., Schneider Y.J., Larondelle Y. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol. Lett. 2006, 164:167-176.
136. Sergent T., Ribonnet L., Kolosova A., Garsou S., Schaut A., De Saeger S., Van Peteghem C., Larondelle Y., Pussemier L., Schneider Y.J. Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level. Food Chem. Toxicol. 2008, 46:813-841.
137. Sharma R.P. Immunotoxicity of mycotoxins. J. Dairy Sci. 1993, 76:892-897.
138. Singh N.D., Sharma A.K., Dwivedi P., Patil R.D., Kumar M. Citrinin and endosulfan induced teratogenic effects in Wistar rats. J. Appl. Toxicol. 2007, 27:143-151.
139. Singh N.D., Sharma A.K., Dwivedi P., Patil R.D., Kumar M. Citrinin and endosulfan induced maternal toxicity in pregnant Wistar rats: pathomorphological study. J. Appl. Toxicol. 2007, 27:589-601.
140. Singh N.D., Sharma A.K., Dwivedi P., Patil R.D., Kumar M. Experimentally induced citrinin and endosulfan toxicity in pregnant Wistar rats: histopathological alterations in liver and kidneys of fetuses. J. Appl. Toxicol. 2008, 28:901-907.
141. Sjöblom M., Säfsten B., Flemström G. Melatonin-induced calcium signaling in clusters of human and rat duodenal enterocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284:G1034-G1044.
142. Smith J.E., Solomons G., Lewis C., Anderson J.G. Role of mycotoxins in human and animal nutrition and health. Nat. Toxins 1995, 3:187-192.
143. Sorenson W.G., Gerberick G.F., Lewis D.M., Castranova V. Toxicity of mycotoxins for the rat pulmonary macrophage in vitro. Environ. Health Perspect. 1986, 66:45-53.
144. Sorenson W.G., Simpson J., Castranova V. Toxicity of the mycotoxin patulin for rat alveolar macrophages. Environ. Res. 1985, 38:407-416.
145. Stark A.A. Threat assessment of mycotoxins as weapons: molecular mechanisms of acute toxicity. J. Food Prot. 2005, 68:1285-1293.
146. Stene L.C., Honeyman M.C., Hoffenberg E.J., Haas J.E., Sokol R.J., Emery L., Taki I., Norris J.M., Erlich H.A., Eisenbarth G.S., Rewers M. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am. J. Gastroenterol. 2006, 101:2333-2340.
147. Stopper H., Schmitt E., Kobras K. Genotoxicity of phytoestrogens. Mutat. Res. 2005, 574:139-155.
148. Strober W., Fuss I., Mannon P. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 2007, 117:514-521.
149. Strugala V., Dettmar P.W., Pearson J.P. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease. Int. J. Clin. Pract. 2008, 62:762-769.
150. Sundstøl Eriksen G., Pettersson H. Lack of de-epoxidation of type B trichothecenes in incubates with human faeces. Food Addit Contam. 2003, 20:579-582.
151. Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening-Baucke V., Ortner M., Weber J., Hoffmann U., Schreiber S., Dietel M., Lochs H. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002, 122:44-54.
152. Tai J.H., Pestka J.J. Impaired murine resistance to Salmonella typhimurium following oral exposure to the trichothecene T-2 toxin. Food Chem. Toxicol. 1988, 26:691-698.
153. Tenk I., Fodor E., Szathmáry C. The effect of pure Fusarium toxins (T-2, F-2, DAS) on the microflora of the gut and on plasma glucocorticoid levels in rat and swine. Zentralbl Bakteriol Mikrobiol Hyg. A 1982, 252:384-393.
154. Tessari E.N., Oliveira C.A., Cardoso A.L., Ledoux D.R., Rottinghaus G.E. Effects of aflatoxin B1 and fumonisin B1 on body weight, antibody titres and histology of broiler chicks. Br. Poult. Sci. 2006, 47:357-364.
155. Van Heel D.A., West J. Recent advances in coeliac disease. Gut 2006, 55:1037-1046.
156. Verdu E.F., Mauro M., Bourgeois J., Armstrong D. Clinical onset of celiac disease after an episode of Campylobacter jejuni enteritis. Can. J. Gastroenterol. 2007, 21:453-455.
157. Verma J., Johri T.S., Swain B.K., Ameena S. Effect of graded levels of aflatoxin, ochratoxin and their combinations on the performance and immune response of broilers. Br. Poult. Sci. 2004, 45:512-518.
158. Waché Y.J., Valat C., Postollec G., Bougeard S., Burel C., Oswald I.P., Fravalo P. Impact of deoxynivalenol on the intestinal microflora of pigs. Int. J. Mol. Sci. 2009, 10:1-17.
159. Wen Z., Fiocchi C. Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?. Clin. Dev. Immunol. 2004, 11:195-204.
160. Wichmann G., Herbarth O., Lehmann I. The mycotoxins citrinin, gliotoxin, and patulin affect interferon-gamma rather than interleukin-4 production in human blood cells. Environ. Toxicol. 2002, 17:211-218.
161. Wild C.P., Gong Y.Y. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 2010, 31:71-82.
162. Zhou S.M., Jiang L.P., Geng C.Y., Cao J., Zhong L.F. Patulin-induced genotoxicity and modulation of glutathione in HepG2 cells. Toxicon 2009, 53:584-586.
163. Zinedine A., Soriano J.M., Moltó J.C., Mañes J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem. Toxicol. 2007, 45:1-18.